Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Contango Signs LLC Agreement To Form Exara Energy, To Fund Encana Program

RELATED NEWS
Trade MCF now with 

Contango Oil and Gas Company (MCF: Quote) said Monday it has entered into a Limited Liability Company Agreement, or LLC Agreement, to form Exaro Energy III LLC.

According to the agreement, Contango will invest up to $82.5 million in Exaro over the next five years together with other parties for an aggregate commitment of $182.5 million. It expects to fund almost $41.3 million in April.

Contango holds about 45 percent stake in Exaro. This is subject to terms allowing another party to acquire up to $15 million of the company's commitment which may decrease the company's stake in Exaro to about 34 percent.

The other prominent members of Exaro include Sageview Capital LP and Exaro II Jonah, a wholly owned subsidiary of Exaro Energy II LLC and an affliate of Jeffries Capital Partners.

Exaro has entered into an Earning and Development Agreement with Encana Oil & Gas Inc. to provide funding of up to $380 million, including the $182.5 million investment, to continue the development drilling program in a defined area of Encana's Jonah field asset.

Upon the total investment, Exaro will earn 32.5 percent of Encana's working interest in a defined joint venture area that comprises about 5,760 gross acres.

Register
To receive FREE breaking news email alerts for Contango Oil & Gas Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.